HY-145191-10mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
HY-145191-100mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
HY-145191-25mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
HY-145191-5mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
HY-145191-50mg
|
MedChemexpress LLC
|
MrgprX2 antagonist-1 [CAS 2642162-06-7]
|
|
COVID-19-immunoregulation
|
|
HY-145997-1mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
HY-145997-10mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
HY-145997-5mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
HY-18169-10mg
|
MedChemexpress LLC
|
Mu T056399 [CAS 1269055-85-7]
|
|
COVID-19-immunoregulation
|
|
HY-18169-5mg
|
MedChemexpress LLC
|
Mu T056399 [CAS 1269055-85-7]
|
|
COVID-19-immunoregulation
|
|
HY-18169-1mL
|
MedChemexpress LLC
|
Mu T056399 [CAS 1269055-85-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-101854-10mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-100mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-200mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-5mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-50mg
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7]
|
|
COVID-19-immunoregulation
|
|
HY-101854-1mL
|
MedChemexpress LLC
|
N6-(2-Phenylethyl)adenosine [CAS 20125-39-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-W011209-25mg
|
MedChemexpress LLC
|
N6-Isopentenyladenosine [CAS 7724-76-7]
|
|
COVID-19-immunoregulation
|
|
HY-W011209-50mg
|
MedChemexpress LLC
|
N6-Isopentenyladenosine [CAS 7724-76-7]
|
|
COVID-19-immunoregulation
|
|
HY-139100B-10mg
|
MedChemexpress LLC
|
N7-Methyl-guanosine-5'-triphosphate-5'-adenosine (diammonium) [CAS 75252-10-7]
|
|
COVID-19-immunoregulation
|
|
HY-139100B-100mg
|
MedChemexpress LLC
|
N7-Methyl-guanosine-5'-triphosphate-5'-adenosine (diammonium) [CAS 75252-10-7]
|
|
COVID-19-immunoregulation
|
|
HY-139100B-5mg
|
MedChemexpress LLC
|
N7-Methyl-guanosine-5'-triphosphate-5'-adenosine (diammonium) [CAS 75252-10-7]
|
|
COVID-19-immunoregulation
|
|
HY-139100B-50mg
|
MedChemexpress LLC
|
N7-Methyl-guanosine-5'-triphosphate-5'-adenosine (diammonium) [CAS 75252-10-7]
|
|
COVID-19-immunoregulation
|
|
HY-136824-1mg
|
MedChemexpress LLC
|
Napyradiomycin A1 [CAS 103106-24-7]
|
|
COVID-19-immunoregulation
|
|
HY-108831-10mg
|
MedChemexpress LLC
|
Natalizumab [CAS 189261-10-7]
|
|
COVID-19-immunoregulation
|
|